You have been diagnosed with colorectal cancer and it is vital that you get as much information as possible about your disease, as well as discuss all possible treatment options with your doctor.

For patients whose cancer is still localized (Stages I and II), the discussion should include the lmmunoscore® test as a new parameter to assess how your immune system is fighting the tumor and to help select the appropriate treatment. for your cancer.

lmmunoscore® is for patients diagnosed with localized colorectal cancer.

It is vital for these patients to get as much information as possible about their illness, as well as discussing all possible treatment options with their physician.

The severity of colorectal cancer is primarily determined by the extent to which the tumor (T) has spread to the affected organ, whether it has spread to the lymph nodes (N) or to other parts of the body through metastases (M). This categorization method, called “TNM“, groups cancer into 5 different stages (0 to 4) that are associated with different chances of recurrence after surgery (prognosis), which determines the choice of treatment.

Despite the above, this approach fails to take into consideration the serious role the immune system has. The immune response can now be accurately measured in clinical practice using lmmunoscore® and thus improve the accuracy of calculating the risk of cancer recurrence.

Contact your Oncologist for more information